18
Publications
1.2K
Citations
15
H-Index
1991
Active since
Rikio Suzuki is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and cancer research.
Top concepts
MedicineCell BiologyOncologyCancer ResearchImmunologyTumor BiologyRadiation OncologyHematologyCell DeathPathology
Publications per year
1991–2023
18
18
Histone deacetylase 3 as a novel therapeutic target in multiple myeloma
J. Minami, Rikio Suzuki, Ralph Mazitschek et al. · Leukemia · 2013 · 158 citations · Full text
Synthetic Lethal Approaches Exploiting DNA Damage in Aggressive Myeloma
Francesca Cottini, Teru Hideshima, Rikio Suzuki et al. · Cancer Discovery · 2015 · 116 citations · Full text
The KDM3A–KLF2–IRF4 axis maintains myeloma cell survival
Hiroto Ohguchi, Teru Hideshima, Manoj Bhasin et al. · Nature Communications · 2016 · 107 citations · Full text
Hematological Malignancy, Cancer Research, Kdm3a–klf2–irf4 Axis +12
Rows per page
1–5 of 18